Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...

A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

Gero secures $17M in new financing, bringing total funding to $34M to advance AI-driven drug discovery for aging and chronic ...

A Boston biotech startup announced a major step towards reversing age-related vision loss. Their experimental gene therapy, ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...